Filtered By:
Condition: Encephalitis
Education: Study
Management: Hospitals
This page shows you your search results in order of date.
Order by Relevance | Date
Total 24 results found since Jan 2013.
Risks of neurological and psychiatric sequelae 2 years after hospitalisation or intensive care admission with COVID-19 compared to admissions for other causes
Brain Behav Immun. 2023 May 30:S0889-1591(23)00132-0. doi: 10.1016/j.bbi.2023.05.014. Online ahead of print.ABSTRACTThe association between COVID-19 and subsequent neurological and psychiatric disorders is well established. However, two important questions remain unanswered. First, what are the risks in those admitted to intensive care unit (ICU) with COVID-19? Admission to ICU is itself associated with neurological and psychiatric sequelae and it is not clear whether COVID-19 further increases those risks or changes their profile. Second, what are the trajectories of neurological and psychiatric risks in patients admitted...
Source: Brain, Behavior, and Immunity - June 1, 2023 Category: Neurology Authors: Harriet Ley Zuzanna Skorniewska Paul J Harrison Maxime Taquet Source Type: research
Association of body mass index with COVID-19-related neurologic sequelae: a retrospective cohort study
This study demonstrates the absence of an association between BMI and neurologic manifestations following acute COVID-19 illness. Prospective studies using standardized data collection tools and direct measures of body fat are warranted to obtain more valid effect estimates.
Source: Clinical and Experimental Medicine - December 16, 2022 Category: Research Source Type: research
Incidence of acute symptomatic seizures
in patients with covid-19: a single-center study
Acta Clin Croat. 2021 Dec;60(Suppl 3):50-56. doi: 10.20471/acc.2021.60.s3.07.ABSTRACTThe most common neurological symptoms in patients with SARS-CoV-2 infection are headache, myalgia, encephalopathy, dizziness, dysgeusia and anosmia, making more than 90 percent of neurological manifestations of COVID-19. Other neurological manifestations such as stroke, movement disorder symptoms or epileptic seizures are rare but rather devastating, with possible lethal outcome. The primary aim of this study was to estimate the prevalence of acute symptomatic seizures among COVID-19 patients, while secondary aim was to determine their pos...
Source: Acta Clinica Croatica - November 21, 2022 Category: General Medicine Authors: Ivana Šušak Sporiš Davor Spori š Zrinka Čolak Romić Petra Bago Ro žanković Silvio Ba šić Source Type: research
Incidence of acute symptomatic seizures
in patients with covid-19: a single-center study
Acta Clin Croat. 2021 Dec;60(Suppl 3):50-56. doi: 10.20471/acc.2021.60.s3.07.ABSTRACTThe most common neurological symptoms in patients with SARS-CoV-2 infection are headache, myalgia, encephalopathy, dizziness, dysgeusia and anosmia, making more than 90 percent of neurological manifestations of COVID-19. Other neurological manifestations such as stroke, movement disorder symptoms or epileptic seizures are rare but rather devastating, with possible lethal outcome. The primary aim of this study was to estimate the prevalence of acute symptomatic seizures among COVID-19 patients, while secondary aim was to determine their pos...
Source: Acta Clinica Croatica - November 21, 2022 Category: General Medicine Authors: Ivana Šušak Sporiš Davor Spori š Zrinka Čolak Romić Petra Bago Ro žanković Silvio Ba šić Source Type: research
Incidence of acute symptomatic seizures
in patients with covid-19: a single-center study
Acta Clin Croat. 2021 Dec;60(Suppl 3):50-56. doi: 10.20471/acc.2021.60.s3.07.ABSTRACTThe most common neurological symptoms in patients with SARS-CoV-2 infection are headache, myalgia, encephalopathy, dizziness, dysgeusia and anosmia, making more than 90 percent of neurological manifestations of COVID-19. Other neurological manifestations such as stroke, movement disorder symptoms or epileptic seizures are rare but rather devastating, with possible lethal outcome. The primary aim of this study was to estimate the prevalence of acute symptomatic seizures among COVID-19 patients, while secondary aim was to determine their pos...
Source: Acta Clinica Croatica - November 21, 2022 Category: General Medicine Authors: Ivana Šušak Sporiš Davor Spori š Zrinka Čolak Romić Petra Bago Ro žanković Silvio Ba šić Source Type: research
Incidence of acute symptomatic seizures
in patients with covid-19: a single-center study
Acta Clin Croat. 2021 Dec;60(Suppl 3):50-56. doi: 10.20471/acc.2021.60.s3.07.ABSTRACTThe most common neurological symptoms in patients with SARS-CoV-2 infection are headache, myalgia, encephalopathy, dizziness, dysgeusia and anosmia, making more than 90 percent of neurological manifestations of COVID-19. Other neurological manifestations such as stroke, movement disorder symptoms or epileptic seizures are rare but rather devastating, with possible lethal outcome. The primary aim of this study was to estimate the prevalence of acute symptomatic seizures among COVID-19 patients, while secondary aim was to determine their pos...
Source: Acta Clinica Croatica - November 21, 2022 Category: General Medicine Authors: Ivana Šušak Sporiš Davor Spori š Zrinka Čolak Romić Petra Bago Ro žanković Silvio Ba šić Source Type: research
Incidence of acute symptomatic seizures
in patients with covid-19: a single-center study
Acta Clin Croat. 2021 Dec;60(Suppl 3):50-56. doi: 10.20471/acc.2021.60.s3.07.ABSTRACTThe most common neurological symptoms in patients with SARS-CoV-2 infection are headache, myalgia, encephalopathy, dizziness, dysgeusia and anosmia, making more than 90 percent of neurological manifestations of COVID-19. Other neurological manifestations such as stroke, movement disorder symptoms or epileptic seizures are rare but rather devastating, with possible lethal outcome. The primary aim of this study was to estimate the prevalence of acute symptomatic seizures among COVID-19 patients, while secondary aim was to determine their pos...
Source: Acta Clinica Croatica - November 21, 2022 Category: General Medicine Authors: Ivana Šušak Sporiš Davor Spori š Zrinka Čolak Romić Petra Bago Ro žanković Silvio Ba šić Source Type: research
Incidence of acute symptomatic seizures
in patients with covid-19: a single-center study
Acta Clin Croat. 2021 Dec;60(Suppl 3):50-56. doi: 10.20471/acc.2021.60.s3.07.ABSTRACTThe most common neurological symptoms in patients with SARS-CoV-2 infection are headache, myalgia, encephalopathy, dizziness, dysgeusia and anosmia, making more than 90 percent of neurological manifestations of COVID-19. Other neurological manifestations such as stroke, movement disorder symptoms or epileptic seizures are rare but rather devastating, with possible lethal outcome. The primary aim of this study was to estimate the prevalence of acute symptomatic seizures among COVID-19 patients, while secondary aim was to determine their pos...
Source: Acta Clinica Croatica - November 21, 2022 Category: General Medicine Authors: Ivana Šušak Sporiš Davor Spori š Zrinka Čolak Romić Petra Bago Ro žanković Silvio Ba šić Source Type: research
Incidence of acute symptomatic seizures
in patients with covid-19: a single-center study
Acta Clin Croat. 2021 Dec;60(Suppl 3):50-56. doi: 10.20471/acc.2021.60.s3.07.ABSTRACTThe most common neurological symptoms in patients with SARS-CoV-2 infection are headache, myalgia, encephalopathy, dizziness, dysgeusia and anosmia, making more than 90 percent of neurological manifestations of COVID-19. Other neurological manifestations such as stroke, movement disorder symptoms or epileptic seizures are rare but rather devastating, with possible lethal outcome. The primary aim of this study was to estimate the prevalence of acute symptomatic seizures among COVID-19 patients, while secondary aim was to determine their pos...
Source: Acta Clinica Croatica - November 21, 2022 Category: General Medicine Authors: Ivana Šušak Sporiš Davor Spori š Zrinka Čolak Romić Petra Bago Ro žanković Silvio Ba šić Source Type: research
Prevention of neurological complications during COVID-19: a retrospective analysis of the ISARIC4C national cohort
This study is the first to focus on the prevention of neurological complications and strongly supports the continued use of both dexamethasone and remdesivir in severe COVID-19. Our results suggest that the established benefit of dexamethasone on mortality in COVID-19 is not associated with an increased burden of long-term neurological disability.
Source: Journal of Neurology, Neurosurgery and Psychiatry - August 12, 2022 Category: Neurosurgery Authors: Grundmann, A., Hardwick, M., Wu, C.-H., Semple, M., Böhning, D., Pett, S., Michael, B., Thomas, R., Galea, I. Tags: Parallel Session 4: COVID Wed 18 May, 1445 - 1600 3 Source Type: research
Mini-Review on SARS-CoV-2 Infection and Neurological Manifestations: A Perspective
CNS Neurol Disord Drug Targets. 2021 Jul 6. doi: 10.2174/1871527320666210706103422. Online ahead of print.ABSTRACTThe coronavirus, also known as SARS-CoV-2 (Severe Acute Respiratory Syndrome Corona Virus-19), with its rapid rate of transmission, has progressed with a great impact on respiratory function and mortality worldwide. The nasal cavity is the promising gateway of SARS-CoV-2 to reach the brain via systemic circulatory distribution. Recent reports have revealed that the loss of involuntary process of breathing control into the brainstem that results in death is a signal of neurological involvement. Early neurologica...
Source: CNS and Neurological Disorders Drug Targets - December 30, 2021 Category: Drugs & Pharmacology Authors: Vishal Chavda Arif Tasleem Jan Dhananjay Yadav Source Type: research
